2 results
Approved WMOWill not start
To compare the progression-free survival (PFS) in subjects with pancreatic islet cell tumors treated with sunitinib at a starting dose of 37.5 mg daily (continuous dosing) with those treated with placebo.
Approved WMOPending
The changes in expiratory flow limitation during increasing levels of external PEEP in COPD patients can be followed with the deltaXrs-8 using FOT.To evaluate whether the deltaXrs is good outcome parameter to determine the external PEEP level needed…